Alcidion Group (ASX:ALC) Quick Ratio: 1.28 (As of Dec. 2025) — Near Median


What is Alcidion Group Quick Ratio?

Alcidion Group ASX:ALC +1.05% Quick Ratio is 1.28 as of Dec. 2025, which is 6% above its 10-year median of 1.21. The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Alcidion Group ranks worse than 51.39% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Alcidion Group's quick ratio for the quarter that ended in Dec. 2025 was 1.28.

Alcidion Group has a quick ratio of 1.28. It generally indicates good short-term financial strength.

The historical rank and industry rank for Alcidion Group's Quick Ratio or its related term are showing as below:

ASX:ALC' s Quick Ratio Range Over the Past 10 Years
Min: 0.42   Med: 1.21   Max: 6.36
Current: 1.28

During the past 13 years, Alcidion Group's highest Quick Ratio was 6.36. The lowest was 0.42. And the median was 1.21.

ASX:ALC's Quick Ratio is ranked worse than
51.39% of 683 companies
in the Healthcare Providers & Services industry
Industry Median: 1.32 vs ASX:ALC: 1.28

Alcidion Group  (ASX:ALC) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Alcidion Group Quick Ratio Related Terms


Alcidion Group Quick Ratio Historical Data

* Premium members only.

The historical data trend for Alcidion Group's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcidion Group Quick Ratio Chart

Alcidion Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.33 1.08 0.99 0.97 1.14

Alcidion Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 0.97 0.93 1.14 1.28

ASX:ALC vs VEEV, BTSG, TEM: Quick Ratio Comparison

For the Health Information Services subindustry, Alcidion Group's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alcidion Group Quick Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Alcidion Group's Quick Ratio falls into.



Alcidion Group Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Alcidion Group's Quick Ratio for the fiscal year that ended in Jun. 2025 is calculated as

Quick Ratio (A: Jun. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(23.687-0)/20.862
=1.14

Alcidion Group's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(28.52-0)/22.328
=1.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 1.28 mean?
Alcidion Group (ASX:ALC) has a Quick Ratio of 1.28 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Alcidion Group and its competitors. This is near median its historical median of 1.21. Over the past decade, Alcidion Group's Quick Ratio has ranged from 0.42 to 6.36. According to the industry distribution chart, Alcidion Group ranks #351 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 51.4%.
Is Alcidion Group's Quick Ratio too high?
Alcidion Group's current Quick Ratio of 1.28 is near median its 10-year median of 1.21. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 6.36. The Healthcare Providers & Services industry median Quick Ratio is 1.32. Alcidion Group's value of 1.28 is 3% below this industry median. Based on the distribution chart, Alcidion Group ranks #351 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Alcidion Group's Quick Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #351 out of 683 companies for Quick Ratio. This places Alcidion Group in the lower half of its industry. The industry median Quick Ratio is 1.32. Alcidion Group's value of 1.28 is 3% below this benchmark. Historically, Alcidion Group's own Quick Ratio has ranged from 0.42 to 6.36 over the past decade. While the company's 10-year median is 1.21 vs. the industry median of 1.32, Alcidion Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Healthcare Providers & Services company?
The median Quick Ratio among Healthcare Providers & Services companies is 1.32, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current Quick Ratio of 1.28 is 3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Quick Ratio is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Quick Ratio is 1.28, which is near median its own 10-year median of 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 20% below its estimated fair value. The current Quick Ratio is 1.28, which is near median its 10-year median of 1.21 and 3% below the Healthcare Providers & Services industry median of 1.32. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Quick Ratio is 1.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alcidion Group Business Description

Address 9 Yarra Street, Level 10, South Yarra, Melbourne, VIC, AUS, 3141
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.